This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Fabienne Lucas

Fabienne (McClanahan) Lucas

Clinical Pathology Resident
Brigham & Women's Hospital
Boston, MA, USA

Residency in Pathology, U.S. (2019-
PhD in Immunology/Hematology, U.K. (2015)
Residency in Hematology/Oncology, Germany (2008-2011)
MD and Doctorate of Medicine (Dr. Med.), Germany (2002-2008)

Scientific Interest and Avenues for Collaboration
As a physician scientist, I am passionate about transforming cancer patient outcomes through an understanding of disease-induced immune mechanisms and their clinical relevance using flow-cytometry and imaging-based approaches. I believe that the highest quality of diagnostic patient workup while pioneering the development of immunological biomarker and diagnostic assays can only be achieved through multidisciplinary exchange, collaboration and translation. I am particularly interested in the effect of targeted therapies on anti-lymphoma and anti-infection properties of neutrophils, in the characterization of immunoediting in the context of clonal evolution and t-AML/MDS development, and in computational approaches for immune biomarker discovery.

Participation / Support of ISAC

  • ¬†ISAC Membership since 2017

Twitter @DrFabLucas